The National Cancer Institute restructured grant award limits and introduced new funding for rare cancer innovation.
Live Poll
Should federal agencies prioritize funding innovation for rare diseases over more common health conditions?
September 24, 2026
FDA Approved New Kidney Cancer Treatment CombinationThe agency cleared a drug regimen for advanced renal cell carcinoma patients.
September 24, 2026
Experts Addressed Clinical Trial Racial DisparitiesA panel identified a persistent lack of Black patient recruitment as a primary barrier to medical research participation.
September 24, 2026
Researchers Evaluated NSAID Risks for Cancer PatientsA study presented in September 2026 analyzed potential toxicity risks among palliative care patients.
September 24, 2026
AI System Developed for Thyroid Cancer PrognosisResearchers created a machine learning model that offers personalized, time-dependent survival predictions.
September 24, 2026
Cancer Patients Faced Higher Infection Risks in StudyResearchers linked triple immunosuppressive therapy to increased infection rates in cancer patients.
September 24, 2026
False Vaccine Claims Recirculated on Social MediaA viral video falsely cites military data to suggest massive spikes in cancer and miscarriage rates.
September 24, 2026
Vaccine Misinformation Threatened Cancer Treatment ProgressRising hesitancy and new state restrictions have complicated the rollout of promising mRNA cancer immunizations.
September 24, 2026
Sellas Life Sciences Shares Slipped OvernightThe company stock declined 1% as investors look ahead to upcoming research presentations.
September 23, 2026
Cancer Rates Rise Among Adults Under 50Medical researchers are investigating the surge of specific cancer diagnoses in younger populations.
September 23, 2026
Texas A&M Researchers Identified Cancer Cell PathwayA study revealed that the URM1 cellular pathway helps cancer cells survive oxidative stress.
